跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,507 条关于
“SY-2101”
全部
2,507
临床试验
1,419
药物
730
机构
5
资讯
353
去年
Syros Pharmaceuticals Announces SELECT-MDS-1 Trial Update and Strategic Realignment
去年
SY-5007 Demonstrates Promising Efficacy in RET-Altered Solid Tumors: Phase 1 Trial Results
9个月前
Quetzal Therapeutics Initiates Phase III Trial of Oral Arsenic Trioxide QTX-2101 for Acute Promyelocytic Leukemia
去年
Blacksmith Medicines Advances Novel Antibiotic FG-2101 Targeting Drug-Resistant Gram-Negative Bacteria
11个月前
Blacksmith Medicines Receives FDA Fast Track and QIDP Designation for Novel Antibiotic FG-2101 Targeting Gram-Negative Superbugs
去年
Pykus Therapeutics Completes Enrollment for Novel Retinal Detachment Treatment Trial
3年前
Syros Pharmaceuticals Advances Clinical Programs in MDS, AML, and APL
去年
Quetzal Therapeutics Launches with $50 Million to Advance Oral Arsenic Trioxide Therapy for Acute Promyelocytic Leukemia
上个月
Vietnamese Scientists Build First Large-Scale Population-Specific Reference Genome, Published in Nature Communications
去年
CEL-SCI Partners with Ergomed for Multikine Confirmatory FDA Registration Study in Head and Neck Cancer
第 1 页,共 36 页
上一页
下一页